Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IMAX
IMAX logo

IMAX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Imax Corp (IMAX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
36.610
1 Day change
1.08%
52 Week Range
43.160
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

IMAX Corp does not present a compelling buy opportunity for a beginner, long-term investor at this moment. While the company has positive growth trends in revenue and gross margin, the significant drop in net income and EPS, coupled with neutral technical indicators and insider selling, suggest caution. Analysts' ratings are generally positive, but the lack of strong proprietary trading signals and mixed sentiment from options data further support a hold recommendation.

Technical Analysis

The MACD histogram is -0.17, indicating bearish momentum, though it is contracting. RSI is neutral at 37.121, and moving averages are converging, suggesting indecision. Key support is at 36.682, and resistance is at 38.416, with the stock currently trading near support levels. No clear bullish or bearish trend is evident.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The high Open Interest Put-Call Ratio indicates bearish sentiment, while the low Option Volume Put-Call Ratio suggests minimal immediate trading activity.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
5

Positive Catalysts

  • Analysts have raised price targets recently, with several maintaining Buy ratings.

  • IMAX is seen as a recession-resistant business model due to its affordability and appeal as a 'staycation' alternative.

  • Strong Q4 revenue growth (+35.11% YoY) and gross margin improvement (+10.77% YoY).

Neutral/Negative Catalysts

  • Insider selling by CEO Richard Gelfond, reducing his holdings by 8.11%.

  • Net income and EPS saw significant declines (-87.99% and -90.00% YoY, respectively).

  • Mixed options sentiment with bearish open interest ratios.

  • Neutral sentiment from hedge funds and insiders.

Financial Performance

In Q4 2025, revenue increased by 35.11% YoY to $125.2M, and gross margin improved to 55.96%. However, net income dropped by 87.99% YoY to $637K, and EPS fell by 90.00% YoY to $0.01, indicating profitability challenges despite revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally positive, with multiple Buy ratings and price targets raised to $45-$48. However, Goldman Sachs maintains a Neutral rating with a lower price target adjustment to $41.

Wall Street analysts forecast IMAX stock price to rise
12 Analyst Rating
Wall Street analysts forecast IMAX stock price to rise
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 36.220
sliders
Low
34
Averages
44
High
47
Current: 36.220
sliders
Low
34
Averages
44
High
47
Roth Capital
Buy
to
Buy
downgrade
$46 -> $44
AI Analysis
2026-04-23
New
Reason
Roth Capital
Price Target
$46 -> $44
AI Analysis
2026-04-23
New
downgrade
Buy
to
Buy
Reason
Roth Capital lowered the firm's price target on Imax to $44 from $46 and keeps a Buy rating on the shares. The company's box office in North America and International, ex-China showed impressive Q1 growth while coming up against tough China comparisons that ultimately proved too large of a headwind to overcome, the analyst tells investors in a research note. Roth adds that it likes the movie lineup spread out over the rest of 2026, especially in the back half of the year, and anticipates further market share expansion for Imax.
Rosenblatt
Buy
maintain
$47
2026-04-20
New
Reason
Rosenblatt
Price Target
$47
2026-04-20
New
maintain
Buy
Reason
Rosenblatt notes that Disney's (DIS) announcement on Friday of "Infinity Vision" knocked Imax (IMAX) down 5% as the news was seen as a competitive threat. However, Infinity Vision is an effort to drum up consumer support for the upcoming release of "Avengers Doomsday" and any future releases that get boxed out of the IMAX network, says the analyst, who calls Disney's announcement "marketing buzz not real competition." The firm, which adds that it is "pounding the table on the stock at current levels," keeps a Buy rating and $47 price target on Imax shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IMAX
Unlock Now

People Also Watch